This review covers the current state-of-the-art of the interplay between p53 and ncRNAs in the regulation of ferroptosis in different cancer cells and offers a glimpse into the unexplored landscape of opportunities, challenges and potential clinical applications raised by these complex interactions. This evidence concerns the gene TP53 and cancer.